Relyvrio: A New FDA-Approved Treatment for Patients With ALS
Drug Topics
DECEMBER 13, 2022
Relyvrio is intended to slow the disease progression of amyotrophic lateral sclerosis.
Sat.Dec 10, 2022 - Fri.Dec 16, 2022
503 
340B program continues to drive shift in care to more expensive hospital settings
PhRMA
DECEMBER 15, 2022
Yet another study highlights the unintended consequences of the 340B program, which is increasing costs for patients and the health care system as a whole. In this case, the Berkeley Research Group (BRG) found that nearly 36% of all Medicare Part B therapy sales occurred at 340B hospitals in 2021 , up nearly 17 percentage points since 2012, meaning care is moving from physician offices and non-340B hospitals to 340B hospitals.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Can pharma quit Twitter? Social strategy evolves as Musk changes the platform
PharmaVoice
DECEMBER 16, 2022
A breakdown of how Twitter’s recent shifts are impacting pharma, and how the industry should navigate the platform in 2023.
Opinion: Hospice care needs saving
STAT
DECEMBER 14, 2022
Hospice in America is gravely ill. An extensive investigation jointly published by The New Yorker and ProPublica documented outright fraud, predatory practices, and flagrant mistreatment by specific publicly traded and private equity-owned hospice companies.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
What’s in a Title?
Drug Topics
DECEMBER 12, 2022
When it comes to practicing pharmacy, do titles and degrees actually matter?
In their own words: Insured Americans support policy reforms that address access and affordability concerns
PhRMA
DECEMBER 14, 2022
A survey of more than 5,000 Americans conducted with Ipsos found that insured Americans want better health care coverage. These insights come from the third installment of the Patient Experience Survey and show how Americans favor policy solutions that improve their ability to navigate and access their care by seeking to remove barriers imposed by insurers and middlemen such as pharmacy benefit managers (PBMs).
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
STAT+: Nine in 10 health care companies with financial stress are owned by private equity
STAT
DECEMBER 14, 2022
Almost 90% of the health care companies deemed to be under financial stress by a leading credit rating agency are owned by private equity , a stark indicator of the toll financial investors have taken on a vital sector. The striking finding is part of a new Moody’s Investors Service report released this week that shows broad turbulence throughout an industry weakened by private equity’s practice of loading companies with debt, making them less resilient to challenges like Covid-19,
2022 Pharmacy Salary Survey
Drug Topics
DECEMBER 14, 2022
Job satisfaction is down and workplace stress is on the rise.
Three things to know about the accelerated approval pathway
PhRMA
DECEMBER 12, 2022
If you or a loved one were to receive a diagnosis of a serious or life-threatening disease, you would likely want access to a U.S. Food and Drug Administration (FDA) approved safe and effective medicine as soon as possible. That’s precisely why the accelerated approval pathway was created back in 1992 at the urging of patient advocates. Since then, it has been a lifeline for millions of patients.
The 2023 PharmaVoice Year in Preview
PharmaVoice
DECEMBER 12, 2022
Here’s a look at how industry leaders are navigating the key issues of 2023.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT+: Bone marrow transplant patients could be spared from ‘bland’ diet, study finds
STAT
DECEMBER 10, 2022
Whenever a hematopoietic cell transplant patient tries to get a family member to sneak food in past the nurses, Federico Stella, a resident hematologist at the University of Milan, remembers. One was a girl who tried to get her sister to bring her a panettone, a Milanese sweet bread usually eaten around the holidays. A week before Christmas, the sister tried to hide the panettone in a bag.
Examining the Impact of the Roe v Wade Decision on Medication Access
Drug Topics
DECEMBER 12, 2022
Investigators set out to evaluate how medication access for certain rheumatic conditions has changed since June 2022.
Using traditional HTAs to determine coverage threatens patient access to medicine
PhRMA
DECEMBER 14, 2022
Concerns about the cost of health care have led to calls for the use of health technology assessments or HTAs by the federal government. This would allow government agencies to make important decisions about patient access to health care based on their determination of the value of new tests and treatments.
At the heart of hematology breakthroughs, a community of researchers and patients comes together
PharmaVoice
DECEMBER 13, 2022
As new and advanced therapies are revealed at the annual meeting of the American Society of Hematology this week, the patients are always at the center.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Dapagliflozin Improves Outcomes in Patients With Chronic Kidney Disease Regardless of Presence of Diabetes
Pharmacy Times
DECEMBER 12, 2022
Dapagliflozin (Farxiga) found effective in lowering the risk of hospitalization for patients with chronic kidney disease, with or without a diagnosis of type 2 diabetes, and increased the number of days alive and out of the hospital.
Technology Tools for Mental Health Screening
Drug Topics
DECEMBER 12, 2022
Online portals are accessible via tablet or computer and can streamline the mental health screening process.
STAT+: Moderna says cancer vaccine reduces melanoma’s return by 44%
STAT
DECEMBER 13, 2022
An experimental cancer vaccine being developed by the biotechnology firm Moderna and the drug giant Merck reduced the risk that melanoma would return after surgery or that patients would die by 44%, the company said. The data, made public in a press release, represent the first evidence of an effective individualized cancer vaccine based on mRNA, the technology used in the Covid shots.
Spotlight on oncology drug development & its future
PharmaVoice
DECEMBER 12, 2022
Learn why an informed, holistic view is needed to succeed in today’s complex and dynamic landscape.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
2023 forecast: Health tech tools begin constructing the Alzheimer's treatment plan
Fierce Healthcare
DECEMBER 16, 2022
2023 forecast: Health tech tools begin constructing the Alzheimer's treatment plan. aburky. Fri, 12/16/2022 - 17:17.
Impact of CBD on the Pharmacokinetics of Methylphenidate
Drug Topics
DECEMBER 14, 2022
With the rise of cannabidiol (CBD) use, understanding how it can impact the effect of other medications is important.
Covid vaccines averted 3 million deaths in U.S., according to new study
STAT
DECEMBER 12, 2022
This Wednesday will mark two years since nurse Sandra Lindsay became the first person in the U.S. to receive a Covid-19 vaccine outside of a clinical trial. A study released Tuesday by the Commonwealth Fund shows that in those two years, the Covid vaccines have averted over 3 million deaths in the U.S. The Centers for Disease Control and Prevention estimates that more than 1 million Americans have died from Covid-19 since the onset of the pandemic.
How one of the world’s most prolific inventors is guiding a plan to tackle all disease
PharmaVoice
DECEMBER 15, 2022
Steve Quake, science head at the Chan Zuckerberg Initiative, is leveraging personal experiences and a deep background in R&D to lead an ambitious 100-year plan.
2023 forecast: Pharmacists push to take on a greater role in patient care
Fierce Healthcare
DECEMBER 16, 2022
2023 forecast: Pharmacists push to take on a greater role in patient care. pminemyer. Fri, 12/16/2022 - 12:39.
Addressing Barriers to MOUDs Faced by People in Incarceration
Drug Topics
DECEMBER 12, 2022
Haylea Hannah, MSPH, PhD, discusses her research on the barriers to medications for opioid use disorder that people who are incarcerated can face and what pharmacists can do to address the barriers.
Keytruda, mRNA Combination Cancer Vaccine Meets Primary Endpoint in Phase 2 Trial
Pharmacy Times
DECEMBER 16, 2022
Merck and Moderna’s adjuvant melanoma treatment shows reduced risk of recurrence or death by 44% compared with pembrolizumab alone.
STAT+: Emerging class of genetically targeted drugs induce remissions in leukemia patients
STAT
DECEMBER 10, 2022
NEW ORLEANS — An emerging class of genetically targeted drugs is inducing remissions in about one-third of patients with advanced leukemia, according to updates Saturday from separate clinical trials. Two biotechs — Syndax Pharmaceuticals and Kura Oncology — are developing their own versions of so-called menin inhibitors that have the potential to become effective treatments for certain types of genetically defined acute myeloid leukemia (AML), a rapidly progressing bone mar
House and Senate Dems want CMS to drop ACO REACH members due to fraud concerns
Fierce Healthcare
DECEMBER 12, 2022
House and Senate Dems want CMS to drop ACO REACH members due to fraud concerns. rking. Mon, 12/12/2022 - 16:08.
Suggestions for Saving: Help Patients Navigate Diabetes Management Costs
Drug Topics
DECEMBER 13, 2022
By offering resources such as free samples and generic alternatives, pharmacists can help patients lower costs.
Celiac Disease May Increase the Risk of Developing Psoriasis
Pharmacy Times
DECEMBER 14, 2022
Study finds gluten-free diets may play an important role in the causality of celiac disease on the development of psoriasis.
Four ways Biogen is tackling digital innovation in neurological disease
pharmaphorum
DECEMBER 11, 2022
Digital transformation in pharma is not a singular endeavour. It can mean everything from patient-facing disease management apps and wearables to background AI dramatically altering drug discovery or radiological imaging. So, when a life sciences company embarks on a project of digital transformation or innovation, it’s really embarking on multiple projects that span the wide world of pharmaceutical operations.
Female Board Members Are Good for Business
PharmExec
DECEMBER 14, 2022
Perspectives from a board member and an aspiring board member on how to increase the number of qualified women on boards.
Opioid Use in Psoriatic Arthritis Is Associated With Higher Health Care Costs, Utilization
Drug Topics
DECEMBER 14, 2022
New pathways of care are needed to improve health care spending.
Prevalence and Types of Myelodysplastic Syndromes (MDS)
Pharmacy Times
DECEMBER 15, 2022
Ryan Haumschild, PharmD, MS, MBA, leads a discussion surrounding myelodysplastic syndrome (MDS).
Let's personalize your content